Hiroshi Koike

443 total citations
53 papers, 297 citations indexed

About

Hiroshi Koike is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Surgery. According to data from OpenAlex, Hiroshi Koike has authored 53 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 21 papers in Rheumatology and 15 papers in Surgery. Recurrent topics in Hiroshi Koike's work include Sarcoma Diagnosis and Treatment (19 papers), Soft tissue tumor case studies (11 papers) and Neurofibromatosis and Schwannoma Cases (8 papers). Hiroshi Koike is often cited by papers focused on Sarcoma Diagnosis and Treatment (19 papers), Soft tissue tumor case studies (11 papers) and Neurofibromatosis and Schwannoma Cases (8 papers). Hiroshi Koike collaborates with scholars based in Japan and United States. Hiroshi Koike's co-authors include Yoshihiro Nishida, Tomohisa Sakai, K. Ikuta, Shunsuke Hamada, Kota Takahashi, Hiroshi Urakawa, Shiro Imagama, Noboru Hara, Yoshie Shimoyama and Makoto Kawaguchi and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and The Journal of Urology.

In The Last Decade

Hiroshi Koike

45 papers receiving 290 citations

Peers

Hiroshi Koike
Ivy John United States
Amir H. Shahlaee United States
R Barnoud France
A. Jacobson United States
Ivy John United States
Hiroshi Koike
Citations per year, relative to Hiroshi Koike Hiroshi Koike (= 1×) peers Ivy John

Countries citing papers authored by Hiroshi Koike

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Koike's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Koike with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Koike more than expected).

Fields of papers citing papers by Hiroshi Koike

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Koike. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Koike. The network helps show where Hiroshi Koike may publish in the future.

Co-authorship network of co-authors of Hiroshi Koike

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Koike. A scholar is included among the top collaborators of Hiroshi Koike based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Koike. Hiroshi Koike is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koike, Hiroshi, et al.. (2025). The utility of apparent diffusion coefficient maps for evaluating chemotherapy response and prognosis in osteosarcoma. Journal of Orthopaedic Science. 31(2). 456–465.
2.
Koike, Hiroshi, et al.. (2025). Implant failure of the Compress prosthesis: a case report. Journal of Medical Case Reports. 19(1). 6–6.
3.
Nishida, Yoshihiro, Hiroyuki Kidokoro, Taichi Kato, et al.. (2025). Selumetinib for symptomatic, inoperable plexiform neurofibromas in pediatric patients with neurofibromatosis type 1: the first single-center real-world case series in Japan. Japanese Journal of Clinical Oncology. 55(4). 372–376.
4.
Liang, Yao, Osamu Maeda, Tomoya Shimokata, et al.. (2023). Potential drug interactions between pazopanib and proton pump inhibitors/potassium-competitive acid blockers in patients with soft tissue sarcoma. International Cancer Conference Journal. 13(1). 63–67. 1 indexed citations
5.
Koike, Hiroshi, Yoshihiro Nishida, Tamayuki Shinomura, et al.. (2022). Possible Repositioning of an Oral Anti-Osteoporotic Drug, Ipriflavone, for Treatment of Inflammatory Arthritis via Inhibitory Activity of KIAA1199, a Novel Potent Hyaluronidase. International Journal of Molecular Sciences. 23(8). 4089–4089. 4 indexed citations
6.
Nakamura, Tomoki, Akihito Nagano, Hiroshi Koike, et al.. (2021). Clinical outcome in patients who underwent amputation due to extremity soft tissue sarcoma: Tokai Musculoskeletal Oncology Consortium study. Japanese Journal of Clinical Oncology. 52(2). 157–162. 6 indexed citations
7.
Nishida, Yoshihiro, K. Ikuta, Hiroshi Urakawa, et al.. (2021). Overexpression of KIAA1199, a novel strong hyaluronidase, is a poor prognostic factor in patients with osteosarcoma. Journal of Orthopaedic Surgery and Research. 16(1). 439–439. 7 indexed citations
8.
Nakamura, Tomoki, Kunihiro Asanuma, Motoshi Takao, et al.. (2021). Clinical Outcome in Soft Tissue Sarcoma Patients with Lung Metastasis Who Received Metastasectomy and/or Radiofrequency Ablation: Tokai Musculoskeletal Oncology Consortium Study. Cancer Management and Research. Volume 13. 8473–8480. 9 indexed citations
9.
Ikuta, K., Yoshihiro Nishida, Satoshi Tsukushi, et al.. (2021). Reconstruction of the extensor mechanism augmented with reverse transferred iliotibial band after proximal tibia tumor resection and mega-prosthetic replacement. The Knee. 33. 102–109. 1 indexed citations
10.
Nishida, Yoshihiro, Shunsuke Hamada, Tomohisa Sakai, et al.. (2021). Less-invasive fascia-preserving surgery for abdominal wall desmoid. Scientific Reports. 11(1). 19379–19379. 3 indexed citations
11.
Sakai, Tomohisa, et al.. (2020). Is mutation analysis of β-catenin useful for the diagnosis of desmoid-type fibromatosis? A systematic review. Japanese Journal of Clinical Oncology. 50(9). 1037–1042. 6 indexed citations
12.
Hamada, Shunsuke, Tomohisa Sakai, Shinji Ito, et al.. (2019). MRI characteristics predict the efficacy of meloxicam treatment in patients with desmoid‐type fibromatosis. Journal of Medical Imaging and Radiation Oncology. 63(6). 751–757. 3 indexed citations
13.
Koike, Hiroshi, Yoshihiro Nishida, Kei Kohno, et al.. (2018). Is immunohistochemical staining for β-catenin the definitive pathological diagnostic tool for desmoid-type fibromatosis? A multi-institutional study. Human Pathology. 84. 155–163. 21 indexed citations
14.
Koike, Hiroshi, et al.. (2017). Safety of Daiobotampito in the Treatment of Acute Diverticulitis of the Colon: A Single-Center, Open-Label, Prospective Trial. The Journal of Alternative and Complementary Medicine. 23(11). 885–889.
15.
Ohi, Masaki, et al.. (2006). A Case of Solitary Splenic Metastasis from Ovarian Cancer. The Japanese Journal of Gastroenterological Surgery. 39(11). 1701–1706. 1 indexed citations
16.
Koike, Hiroshi, et al.. (2006). Idiopathic retroperitoneal fibrosis associated with IgG4‐positive‐plasmacyte infiltrations and idiopathic chronic pancreatitis. International Journal of Urology. 13(11). 1442–1444. 25 indexed citations
17.
Ohi, Masaki, et al.. (2005). A Case of G-CSF-producing Metastatic Gastric Cancer from Lung Carcinoma. The Japanese Journal of Gastroenterological Surgery. 38(6). 620–625. 1 indexed citations
18.
Yoshizumi, Yutaka, et al.. (1998). Simultaneous Resection of Gastric Carcinoma and Splenectomy in a Patient with Polycythemia Vera: Report of a Case. Surgery Today. 28(2). 197–200. 8 indexed citations
19.
Yoshizumi, Yutaka, et al.. (1997). Successful combined resection of carcinoma of the esophagus and adrenal metastasis: Report of a case. Surgery Today. 27(4). 330–333. 9 indexed citations
20.
Nakada, T., et al.. (1987). Clinical analysis of ureteral tumours with or without renal pelvic neoplasms. International Urology and Nephrology. 19(4). 377–384. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026